Significant Research Presented at the AHCC International Research Symposium
PURCHASE, N.Y., Sept. 16 /PRNewswire/ -- The 16th International AHCC(R)
(Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on
July 26th and 27th. The Symposium hosted by the AHCC Research Association was
attended by over 300 medical doctors and researchers from around the world
that presented and discussed research studies completed with AHCC.
Individuals attending this year's event included representatives from Harvard
Medical School,
Significant preliminary findings from a
Study participants were normal healthy individuals 50 years or older and were provided AHCC for 60 days. Scientists measured the production of two key cytokines -- Interferon (IFN-y) and Tumor Necrosis Factor (TNF-alpha) -- at the baseline, 30 days and 60 days. These two cytokines are believed to serve a major role in the body's natural method of preventing the formation and spread of abnormal and cancerous cells.
The two keynote presentations from researchers in Japan focused on the
value of AHCC in cancer therapy. Professor Emeritus Masuo Hosokawa of
A scientific review study soon to be published in the upcoming Nutritional
Reviews Journal was presented by Dr. Barry Ritz of
"AHCC continues to demonstrate its essential role for healthy immune function," said Fred Pescatore, M.D., M.P.H., of the Center for Integrative and Complementary Medicine, and medical director for the U.S. AHCC Research Association in response to the research presented at this year's Symposium.
AHCC has been the subject of over 80 research studies worldwide including
studies completed at
What is AHCC (Active Hexose Correlated Compound)?
AHCC is derived from the hybridization of several subspecies of medicinal mushroom, cultivated in Japan and then produced from a specialized manufacturing process. AHCC is the leading immune-enhancing supplement in Japan and is utilized by over 700 hospitals and healthcare facilities worldwide as a standard preventative supplement for incoming patients to help reduce the risk of hospital infections as well as supporting the body's fight against the formation of abnormal cells.*
AHCC is manufactured by Amino Up Chemical Company in Sapporo, Japan and is distributed in the United States by Maypro Industries. Maypro sells AHCC to a number of leading supplement companies including Quality of Life Laboratories, a subsidiary of Maypro.
The AHCC Research Association was founded in 1986 to promote further study. Each year since 1994, over 300 medical doctors and researchers have gathered in Sapporo, Japan for the AHCC Research Association Symposium to share and discuss the latest developments.
To learn more about AHCC, visit the AHCC Research Association Web site at http://www.ahccresearch.com
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or mitigate disease.
SOURCE AHCC Research Association
International News / Press Release source: PR Newswire
Copyright PR Newswire. All Rights Reserved.